Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus

Patrick Michael Shaughn O'Brien, Torbjorn Bäckström, Candace Brown, Lorraine Dennerstein, Jean Endicott, C. Neill Epperson, Elias Eriksson, Ellen Freeman, Uriel Halbreich, Khaled M.K. Ismail, Nicholas Panay, Teri Pearlstein, Andrea Rapkin, Robert Reid, Peter Schmidt, Meir Steiner, John Studd, Kimberley Yonkers

Research output: Contribution to journalReview article

111 Citations (Scopus)

Abstract

Premenstrual disorders (PMD) are characterised by a cluster of somatic and psychological symptoms of varying severity that occur during the luteal phase of the menstrual cycle and resolve during menses (Freeman and Sondheimer, Prim Care Companion J Clin Psychiatry 5:30-39, 2003; Halbreich, Gynecol Endocrinol 19:320-334, 2004). Although PMD have been widely recognised for many decades, their precise cause is still unknown and there are no definitive, universally accepted diagnostic criteria. To consider this issue, an international multidisciplinary group of experts met at a face-to-face consensus meeting to review current definitions and diagnostic criteria for PMD. This was followed by extensive correspondence. The consensus group formally became established as the International Society for Premenstrual Disorders (ISPMD). The inaugural meeting of the ISPMD was held in Montreal in September 2008. The primary aim was to provide a unified approach for the diagnostic criteria of PMD, their quantification and guidelines on clinical trial design. This report summarises their recommendations. It is hoped that the criteria proposed here will inform discussions of the next edition of the World Health Organisation's International Classification of Diseases (ICD-11), and the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) criteria that are currently under consideration. It is also hoped that the proposed definitions and guidelines could be used by all clinicians and investigators to provide a consistent approach to the diagnosis and treatment of PMD and to aid scientific and clinical research in this field.

Original languageEnglish (US)
Pages (from-to)13-21
Number of pages9
JournalArchives of Women's Mental Health
Volume14
Issue number1
DOIs
StatePublished - Feb 1 2011

Fingerprint

Diagnostic and Statistical Manual of Mental Disorders
Psychiatry
Consensus
Guidelines
Menstruation
Luteal Phase
International Classification of Diseases
Research Personnel
Clinical Trials
Psychology
Research
Medically Unexplained Symptoms

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology
  • Psychiatry and Mental health

Cite this

Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders : The ISPMD Montreal consensus. / O'Brien, Patrick Michael Shaughn; Bäckström, Torbjorn; Brown, Candace; Dennerstein, Lorraine; Endicott, Jean; Epperson, C. Neill; Eriksson, Elias; Freeman, Ellen; Halbreich, Uriel; Ismail, Khaled M.K.; Panay, Nicholas; Pearlstein, Teri; Rapkin, Andrea; Reid, Robert; Schmidt, Peter; Steiner, Meir; Studd, John; Yonkers, Kimberley.

In: Archives of Women's Mental Health, Vol. 14, No. 1, 01.02.2011, p. 13-21.

Research output: Contribution to journalReview article

O'Brien, PMS, Bäckström, T, Brown, C, Dennerstein, L, Endicott, J, Epperson, CN, Eriksson, E, Freeman, E, Halbreich, U, Ismail, KMK, Panay, N, Pearlstein, T, Rapkin, A, Reid, R, Schmidt, P, Steiner, M, Studd, J & Yonkers, K 2011, 'Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus', Archives of Women's Mental Health, vol. 14, no. 1, pp. 13-21. https://doi.org/10.1007/s00737-010-0201-3
O'Brien, Patrick Michael Shaughn ; Bäckström, Torbjorn ; Brown, Candace ; Dennerstein, Lorraine ; Endicott, Jean ; Epperson, C. Neill ; Eriksson, Elias ; Freeman, Ellen ; Halbreich, Uriel ; Ismail, Khaled M.K. ; Panay, Nicholas ; Pearlstein, Teri ; Rapkin, Andrea ; Reid, Robert ; Schmidt, Peter ; Steiner, Meir ; Studd, John ; Yonkers, Kimberley. / Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders : The ISPMD Montreal consensus. In: Archives of Women's Mental Health. 2011 ; Vol. 14, No. 1. pp. 13-21.
@article{69a16e68312c4ee9863c3b435c494294,
title = "Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus",
abstract = "Premenstrual disorders (PMD) are characterised by a cluster of somatic and psychological symptoms of varying severity that occur during the luteal phase of the menstrual cycle and resolve during menses (Freeman and Sondheimer, Prim Care Companion J Clin Psychiatry 5:30-39, 2003; Halbreich, Gynecol Endocrinol 19:320-334, 2004). Although PMD have been widely recognised for many decades, their precise cause is still unknown and there are no definitive, universally accepted diagnostic criteria. To consider this issue, an international multidisciplinary group of experts met at a face-to-face consensus meeting to review current definitions and diagnostic criteria for PMD. This was followed by extensive correspondence. The consensus group formally became established as the International Society for Premenstrual Disorders (ISPMD). The inaugural meeting of the ISPMD was held in Montreal in September 2008. The primary aim was to provide a unified approach for the diagnostic criteria of PMD, their quantification and guidelines on clinical trial design. This report summarises their recommendations. It is hoped that the criteria proposed here will inform discussions of the next edition of the World Health Organisation's International Classification of Diseases (ICD-11), and the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) criteria that are currently under consideration. It is also hoped that the proposed definitions and guidelines could be used by all clinicians and investigators to provide a consistent approach to the diagnosis and treatment of PMD and to aid scientific and clinical research in this field.",
author = "O'Brien, {Patrick Michael Shaughn} and Torbjorn B{\"a}ckstr{\"o}m and Candace Brown and Lorraine Dennerstein and Jean Endicott and Epperson, {C. Neill} and Elias Eriksson and Ellen Freeman and Uriel Halbreich and Ismail, {Khaled M.K.} and Nicholas Panay and Teri Pearlstein and Andrea Rapkin and Robert Reid and Peter Schmidt and Meir Steiner and John Studd and Kimberley Yonkers",
year = "2011",
month = "2",
day = "1",
doi = "10.1007/s00737-010-0201-3",
language = "English (US)",
volume = "14",
pages = "13--21",
journal = "Archives of Women's Mental Health",
issn = "1434-1816",
publisher = "Springer Wien",
number = "1",

}

TY - JOUR

T1 - Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders

T2 - The ISPMD Montreal consensus

AU - O'Brien, Patrick Michael Shaughn

AU - Bäckström, Torbjorn

AU - Brown, Candace

AU - Dennerstein, Lorraine

AU - Endicott, Jean

AU - Epperson, C. Neill

AU - Eriksson, Elias

AU - Freeman, Ellen

AU - Halbreich, Uriel

AU - Ismail, Khaled M.K.

AU - Panay, Nicholas

AU - Pearlstein, Teri

AU - Rapkin, Andrea

AU - Reid, Robert

AU - Schmidt, Peter

AU - Steiner, Meir

AU - Studd, John

AU - Yonkers, Kimberley

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Premenstrual disorders (PMD) are characterised by a cluster of somatic and psychological symptoms of varying severity that occur during the luteal phase of the menstrual cycle and resolve during menses (Freeman and Sondheimer, Prim Care Companion J Clin Psychiatry 5:30-39, 2003; Halbreich, Gynecol Endocrinol 19:320-334, 2004). Although PMD have been widely recognised for many decades, their precise cause is still unknown and there are no definitive, universally accepted diagnostic criteria. To consider this issue, an international multidisciplinary group of experts met at a face-to-face consensus meeting to review current definitions and diagnostic criteria for PMD. This was followed by extensive correspondence. The consensus group formally became established as the International Society for Premenstrual Disorders (ISPMD). The inaugural meeting of the ISPMD was held in Montreal in September 2008. The primary aim was to provide a unified approach for the diagnostic criteria of PMD, their quantification and guidelines on clinical trial design. This report summarises their recommendations. It is hoped that the criteria proposed here will inform discussions of the next edition of the World Health Organisation's International Classification of Diseases (ICD-11), and the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) criteria that are currently under consideration. It is also hoped that the proposed definitions and guidelines could be used by all clinicians and investigators to provide a consistent approach to the diagnosis and treatment of PMD and to aid scientific and clinical research in this field.

AB - Premenstrual disorders (PMD) are characterised by a cluster of somatic and psychological symptoms of varying severity that occur during the luteal phase of the menstrual cycle and resolve during menses (Freeman and Sondheimer, Prim Care Companion J Clin Psychiatry 5:30-39, 2003; Halbreich, Gynecol Endocrinol 19:320-334, 2004). Although PMD have been widely recognised for many decades, their precise cause is still unknown and there are no definitive, universally accepted diagnostic criteria. To consider this issue, an international multidisciplinary group of experts met at a face-to-face consensus meeting to review current definitions and diagnostic criteria for PMD. This was followed by extensive correspondence. The consensus group formally became established as the International Society for Premenstrual Disorders (ISPMD). The inaugural meeting of the ISPMD was held in Montreal in September 2008. The primary aim was to provide a unified approach for the diagnostic criteria of PMD, their quantification and guidelines on clinical trial design. This report summarises their recommendations. It is hoped that the criteria proposed here will inform discussions of the next edition of the World Health Organisation's International Classification of Diseases (ICD-11), and the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) criteria that are currently under consideration. It is also hoped that the proposed definitions and guidelines could be used by all clinicians and investigators to provide a consistent approach to the diagnosis and treatment of PMD and to aid scientific and clinical research in this field.

UR - http://www.scopus.com/inward/record.url?scp=79751529381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79751529381&partnerID=8YFLogxK

U2 - 10.1007/s00737-010-0201-3

DO - 10.1007/s00737-010-0201-3

M3 - Review article

C2 - 21225438

AN - SCOPUS:79751529381

VL - 14

SP - 13

EP - 21

JO - Archives of Women's Mental Health

JF - Archives of Women's Mental Health

SN - 1434-1816

IS - 1

ER -